Pharmanutra SpA
MIL:PHN

Watchlist Manager
Pharmanutra SpA Logo
Pharmanutra SpA
MIL:PHN
Watchlist
Price: 64.6 EUR -0.46% Market Closed
Market Cap: €625.3m

Net Margin

13.4%
Current
Declining
by 1.5%
vs 3-y average of 14.8%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
13.4%
=
Net Income
€24.2m
/
Revenue
€180.4m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
13.4%
=
Net Income
€24.2m
/
Revenue
€180.4m

Peer Comparison

Country Company Market Cap Net
Margin
IT
Pharmanutra SpA
MIL:PHN
617.6m EUR
Loading...
FR
L'Oreal SA
PAR:OR
205.1B EUR
Loading...
UK
Unilever PLC
LSE:ULVR
119.9B GBP
Loading...
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.7T INR
Loading...
UK
HALEON PLC
LSE:HLN
33.8B GBP
Loading...
US
Estee Lauder Companies Inc
NYSE:EL
42.3B USD
Loading...
DE
Beiersdorf AG
XETRA:BEI
21.3B EUR
Loading...
JP
Kao Corp
TSE:4452
2.8T JPY
Loading...
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.3T INR
Loading...
IN
Dabur India Ltd
NSE:DABUR
920.5B INR
Loading...
CA
Relevium Technologies Inc
XTSX:RLV
12.2B CAD
Loading...

Market Distribution

Higher than 76% of companies in Italy
Percentile
76th
Based on 1 294 companies
76th percentile
13.4%
Low
-24 712% — 1.6%
Typical Range
1.6% — 10.1%
High
10.1% — 3 667.8%
Distribution Statistics
Italy
Min -24 712%
30th Percentile 1.6%
Median 5.3%
70th Percentile 10.1%
Max 3 667.8%

Pharmanutra SpA
Glance View

Pharmanutra SpA develops nutraceutical products and medical devices. The company is headquartered in Pisa, Pisa. The company went IPO on 2017-07-18. The firm develops nutraceutical products and medical devices. The company focuses on studying and producing formulations that are backed up in scientific research. The company is able to cover all stages of the development of a product, from its design, formulation and registration to its marketing, distribution and training of its commercial representatives. The firm offers Gestalys DHA, a nutritional supplement; Cetilar, a massage coadiuvant, improves and brings relief to joints affected by osteoarthritis; Cetilar patch, a transdermic patch containing a concentrated formulation of cetylated fatty acids (CFA) esters; SiderAL Forte; CardioSiderAL; SiderAL Folico; SiderAL; Bonecal and Novomega, among others.

PHN Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
13.4%
=
Net Income
€24.2m
/
Revenue
€180.4m
What is Pharmanutra SpA's current Net Margin?

The current Net Margin for Pharmanutra SpA is 13.4%, which is below its 3-year median of 14.8%.

How has Net Margin changed over time?

Over the last 3 years, Pharmanutra SpA’s Net Margin has decreased from 20.1% to 13.4%. During this period, it reached a low of 12.3% on Mar 31, 2024 and a high of 20.1% on Aug 30, 2022.

Back to Top